JP5950938B2 - マイクロカプセル化プロバイオティクス物質および製造方法 - Google Patents
マイクロカプセル化プロバイオティクス物質および製造方法 Download PDFInfo
- Publication number
- JP5950938B2 JP5950938B2 JP2013549833A JP2013549833A JP5950938B2 JP 5950938 B2 JP5950938 B2 JP 5950938B2 JP 2013549833 A JP2013549833 A JP 2013549833A JP 2013549833 A JP2013549833 A JP 2013549833A JP 5950938 B2 JP5950938 B2 JP 5950938B2
- Authority
- JP
- Japan
- Prior art keywords
- dry powder
- solid particles
- microspheres
- solution
- probiotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000006041 probiotic Substances 0.000 title claims description 77
- 235000018291 probiotics Nutrition 0.000 title claims description 77
- 230000000529 probiotic effect Effects 0.000 title claims description 60
- 238000004519 manufacturing process Methods 0.000 title claims description 15
- 239000000463 material Substances 0.000 title description 19
- 239000004005 microsphere Substances 0.000 claims description 127
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 71
- 235000002639 sodium chloride Nutrition 0.000 claims description 53
- 239000000843 powder Substances 0.000 claims description 48
- 239000002245 particle Substances 0.000 claims description 47
- 239000000203 mixture Substances 0.000 claims description 42
- 238000000034 method Methods 0.000 claims description 34
- 239000008273 gelatin Substances 0.000 claims description 32
- 229920000159 gelatin Polymers 0.000 claims description 32
- 239000007787 solid Substances 0.000 claims description 31
- 235000010443 alginic acid Nutrition 0.000 claims description 30
- 229920000615 alginic acid Polymers 0.000 claims description 30
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 28
- 229940072056 alginate Drugs 0.000 claims description 28
- 238000000576 coating method Methods 0.000 claims description 28
- 239000011248 coating agent Substances 0.000 claims description 27
- 108010010803 Gelatin Proteins 0.000 claims description 26
- 235000019322 gelatine Nutrition 0.000 claims description 26
- 235000011852 gelatine desserts Nutrition 0.000 claims description 26
- 235000011187 glycerol Nutrition 0.000 claims description 24
- 244000005700 microbiome Species 0.000 claims description 22
- 238000005266 casting Methods 0.000 claims description 21
- 239000012798 spherical particle Substances 0.000 claims description 15
- 238000005345 coagulation Methods 0.000 claims description 14
- 230000015271 coagulation Effects 0.000 claims description 14
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 13
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 13
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 13
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 13
- 230000008569 process Effects 0.000 claims description 13
- 235000015097 nutrients Nutrition 0.000 claims description 12
- 229920001661 Chitosan Polymers 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 239000001856 Ethyl cellulose Substances 0.000 claims description 9
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 9
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 9
- 229920001249 ethyl cellulose Polymers 0.000 claims description 9
- 230000004083 survival effect Effects 0.000 claims description 9
- 238000009826 distribution Methods 0.000 claims description 8
- 229920001817 Agar Polymers 0.000 claims description 7
- 239000008272 agar Substances 0.000 claims description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- 235000010419 agar Nutrition 0.000 claims description 6
- 235000010980 cellulose Nutrition 0.000 claims description 6
- 229920002678 cellulose Polymers 0.000 claims description 6
- 239000001913 cellulose Substances 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 239000004373 Pullulan Substances 0.000 claims description 5
- 229920001218 Pullulan Polymers 0.000 claims description 5
- 238000001125 extrusion Methods 0.000 claims description 5
- 239000000499 gel Substances 0.000 claims description 5
- 230000000813 microbial effect Effects 0.000 claims description 5
- 229920001282 polysaccharide Polymers 0.000 claims description 5
- 239000005017 polysaccharide Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 235000019423 pullulan Nutrition 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 4
- 229920001525 carrageenan Polymers 0.000 claims description 4
- 239000002702 enteric coating Substances 0.000 claims description 4
- 238000009505 enteric coating Methods 0.000 claims description 4
- 239000000416 hydrocolloid Substances 0.000 claims description 4
- 229920001277 pectin Polymers 0.000 claims description 4
- 239000001814 pectin Substances 0.000 claims description 4
- 235000010987 pectin Nutrition 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 4
- 235000010323 ascorbic acid Nutrition 0.000 claims description 3
- 239000011668 ascorbic acid Substances 0.000 claims description 3
- 229960005070 ascorbic acid Drugs 0.000 claims description 3
- 235000010418 carrageenan Nutrition 0.000 claims description 3
- 239000000679 carrageenan Substances 0.000 claims description 3
- 229940113118 carrageenan Drugs 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 239000003981 vehicle Substances 0.000 claims description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 3
- 229920003134 Eudragit® polymer Polymers 0.000 claims description 2
- 229920002488 Hemicellulose Polymers 0.000 claims description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 claims description 2
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- 235000006708 antioxidants Nutrition 0.000 claims description 2
- 229940041514 candida albicans extract Drugs 0.000 claims description 2
- 235000015165 citric acid Nutrition 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 229960005150 glycerol Drugs 0.000 claims description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- 235000021243 milk fat Nutrition 0.000 claims description 2
- 150000002772 monosaccharides Chemical class 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 108090000623 proteins and genes Proteins 0.000 claims description 2
- 102000004169 proteins and genes Human genes 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 239000008158 vegetable oil Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 239000012138 yeast extract Substances 0.000 claims description 2
- 239000004246 zinc acetate Substances 0.000 claims description 2
- 229960000314 zinc acetate Drugs 0.000 claims description 2
- 235000013904 zinc acetate Nutrition 0.000 claims description 2
- 235000005074 zinc chloride Nutrition 0.000 claims description 2
- 239000011592 zinc chloride Substances 0.000 claims description 2
- 229960001939 zinc chloride Drugs 0.000 claims description 2
- 235000000193 zinc lactate Nutrition 0.000 claims description 2
- 239000011576 zinc lactate Substances 0.000 claims description 2
- 229940050168 zinc lactate Drugs 0.000 claims description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims 2
- -1 alkaline earth metal halogen salt Chemical class 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 104
- 239000000243 solution Substances 0.000 description 81
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 60
- 239000011780 sodium chloride Substances 0.000 description 52
- 239000000725 suspension Substances 0.000 description 26
- 238000000926 separation method Methods 0.000 description 25
- 238000005406 washing Methods 0.000 description 25
- 239000011159 matrix material Substances 0.000 description 20
- 239000007864 aqueous solution Substances 0.000 description 19
- 239000011324 bead Substances 0.000 description 18
- 230000035899 viability Effects 0.000 description 15
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 description 13
- 229940009289 bifidobacterium lactis Drugs 0.000 description 13
- 238000005336 cracking Methods 0.000 description 12
- 239000011162 core material Substances 0.000 description 10
- 238000010790 dilution Methods 0.000 description 9
- 239000012895 dilution Substances 0.000 description 9
- 239000011550 stock solution Substances 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 229920002907 Guar gum Polymers 0.000 description 8
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 239000000665 guar gum Substances 0.000 description 8
- 229960002154 guar gum Drugs 0.000 description 8
- 239000008108 microcrystalline cellulose Substances 0.000 description 8
- 229940016286 microcrystalline cellulose Drugs 0.000 description 8
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 8
- 238000003860 storage Methods 0.000 description 8
- 235000010417 guar gum Nutrition 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 238000001035 drying Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 5
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 5
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 5
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 5
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 4
- 229920002774 Maltodextrin Polymers 0.000 description 4
- 239000005913 Maltodextrin Substances 0.000 description 4
- 239000007884 disintegrant Substances 0.000 description 4
- 238000005538 encapsulation Methods 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 229940035034 maltodextrin Drugs 0.000 description 4
- 239000003094 microcapsule Substances 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 150000004804 polysaccharides Chemical class 0.000 description 4
- 238000001694 spray drying Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000011257 shell material Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000008174 sterile solution Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000004227 calcium gluconate Substances 0.000 description 2
- 229960004494 calcium gluconate Drugs 0.000 description 2
- 235000013927 calcium gluconate Nutrition 0.000 description 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 2
- 239000001527 calcium lactate Substances 0.000 description 2
- 229960002401 calcium lactate Drugs 0.000 description 2
- 235000011086 calcium lactate Nutrition 0.000 description 2
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000007407 health benefit Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000008176 lyophilized powder Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 2
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920000294 Resistant starch Polymers 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 108010055615 Zein Proteins 0.000 description 1
- GAMPNQJDUFQVQO-UHFFFAOYSA-N acetic acid;phthalic acid Chemical compound CC(O)=O.OC(=O)C1=CC=CC=C1C(O)=O GAMPNQJDUFQVQO-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910001508 alkali metal halide Inorganic materials 0.000 description 1
- 229910001615 alkaline earth metal halide Inorganic materials 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940031012 anti-acne preparations Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000011258 core-shell material Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000007580 dry-mixing Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000012395 formulation development Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 1
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000021254 resistant starch Nutrition 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 229940023144 sodium glycolate Drugs 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- JEJAMASKDTUEBZ-UHFFFAOYSA-N tris(1,1,3-tribromo-2,2-dimethylpropyl) phosphate Chemical compound BrCC(C)(C)C(Br)(Br)OP(=O)(OC(Br)(Br)C(C)(C)CBr)OC(Br)(Br)C(C)(C)CBr JEJAMASKDTUEBZ-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/256—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from seaweeds, e.g. alginates, agar or carrageenan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/275—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/275—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of animal origin, e.g. chitin
- A23L29/281—Proteins, e.g. gelatin or collagen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
- A23P20/10—Coating with edible coatings, e.g. with oils or fats
- A23P20/12—Apparatus or processes for applying powders or particles to foodstuffs, e.g. for breading; Such apparatus combined with means for pre-moistening or battering
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5052—Proteins, e.g. albumin
- A61K9/5057—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Dispersion Chemistry (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Description
微結晶性セルロース(MCC)と崩壊剤とを乾式混合する工程と、
MCCと崩壊剤との混合物を、凍結乾燥プロバイオティクス、安定剤および精製水を含む水性分散剤と共に顆粒化して、押し出し可能なペーストを生成する工程と、
前述の押し出し可能なペーストを断片の形態で押し出す工程と、
前述の断片を球形化して、マイクロスフィアのコアを形成する工程と、
コアの残余の水分を乾燥する工程と、
前述のコアをコーティングして、マイクロスフィアを得る工程と、を含む。
プロバイオティクス微生物の懸濁液を準備する工程と、
少なくとも1つのデキストリンを含み、また場合により、少なくとも1つの二糖類またはオリゴ糖を含む、マトリックスを準備する工程と、
プロバイオティクス微生物の懸濁液をマトリックスに封入し、マイクロカプセルを得る工程と、
コーティング組成物でマイクロカプセルをコーティングする工程と、を含む。
微生物調製物と更なる成分とを混合する工程と、
混合物を乾燥する工程と、
圧力下で混合物を圧縮して、ペレットを得る工程と、
ペレットをコーティングする工程と、を含む。
生存プロバイオティクス微生物調製物と、少なくとも栄養源を含む担体相とを混合する工程と、
前述の生存プロバイオティクス微生物と前述の担体相との混合物を押し出して、マイクロスフィアを製造する工程と、
凝固溶液を収容した槽で前述のマイクロスフィアを回収する工程と、を含む。
アルギン酸塩‐ECビーズとプロバイオティクスペースト
エチルセルロース外部コーティングを有する、アルギン酸塩から製造されたマトリックス中のL.Rhamnosus(ラクトバチルス・ラムノサス)のマイクロスフィアを、次に示すプロトコールによって製造した。
アルギン酸塩‐ゼラチンビーズとプロバイオティクスペースト
ゼラチンコーティングを有する、アルギン酸塩マトリックス中のL.Rhamnosus(ラクトバチルス・ラムノサス)のマイクロスフィアを、次に言及するプロトコールによって製造した。
アルギン酸塩‐CMC‐ゼラチンビーズとプロバイオティクスペースト
カルボキシメチルセルロースコーティングおよびゲル化架橋コーティングを有する、アルギン酸塩マトリックス中のL.Rhamnosus(ラクトバチルス・ラムノサス)のマイクロスフィアを、次に示すように製造した。
ゼラチン‐グアーガムCMCビーズとプロバイオティクスペースト
グアーガムおよびカルボキシメチルセルロースでコーティングされた、ゼラチンマトリックス中のBifidobacterium Lactis(ビフィドバクテリウム・ラクティス)のマイクロスフィアを、次に示すように製造した。
アルギン酸塩‐キトサン‐ゼラチンビーズとプロバイオティクスペースト
キトサンコーティングと、更にゼラチンコーティングとを有する、アルギン酸塩マトリックス中のL.Rhamnosus(ラクトバチルス・ラムノサス)のマイクロスフィアを、次に示すように製造した。
アルギン酸塩ビーズとプロバイオティクスペースト
アルギン酸塩マトリックス中のL.Rhamnosus(ラクトバチルス・ラムノサス)のマイクロスフィアを、次に示すように製造した。
試料1:グルコース/グリセロールと共に乾燥させたLactobacillus rhamnosus(ラクトバチルス・ラムノサス)マイクロスフィア、径約400〜900マイクロメートル。
試料2:グルコース/グリセロール中に湿潤させたLactobacillus rhamnosus(ラクトバチルス・ラムノサス)マイクロスフィア、径約800〜1200マイクロメートル。
初期重量:
試料1:2回のうちの1回目:100 mg 2回のうちの2回目:103 mg 平均:101.5 mg
試料2:2回のうちの1回目:102 mg 2回のうちの2回目:99 mg 平均:100.5 mg
試料1:2.9 ml中に101.5 mg=29.6倍希釈。
試料2:1.9 ml中に100.5 mg=19.9倍希釈。
試料1:192.103×29.6=5.68 106 cfu/gマイクロスフィア(乾燥重量)
試料2:635.103×19.9=1.26 107 cfu/gマイクロスフィア(湿重量)
アルギン酸塩‐CMC‐ゼラチンビーズと凍結乾燥プロバイオティクス
カルボキシメチルセルロースおよびゼラチンでコーティングされた、アルギン酸塩マトリックス中のL.rhamnosus(ラクトバチルス・ラムノサス)のマイクロスフィアを、次に示すように製造した。
アルギン酸塩‐ECビーズと凍結乾燥プロバイオティクス
エチルセルロースでコーティングされた、アルギン酸塩マトリックス中のL.rhamnosus(ラクトバチルス・ラムノサス)のマイクロスフィアを、次に示すように製造した。
アルギン酸塩‐ゼラチンビーズと凍結乾燥プロバイオティクス
ゼラチンでコーティングされた、アルギン酸塩マトリックス中のL.rhamnosus(ラクトバチルス・ラムノサス)のマイクロスフィアを、次に示すように製造した。
ゲル化グアーガムCMCビーズと凍結乾燥プロバイオティクス
グアーガムおよびカルボキシメチルセルロースでコーティングされた、ゼラチンマトリックス中のBifidobacterium lactis(ビフィドバクテリウム・ラクティス)のマイクロスフィアを、次に示すように製造した。
アルギン酸塩‐キトサン‐ゼラチンビーズと凍結乾燥プロバイオティクス
キトサンおよびゼラチンでコーティングされた、アルギン酸塩マトリックス中のL.rhamnosus(ラクトバチルス・ラムノサス)のマイクロスフィアを、次に示すように製造した。
アルギン酸塩ビーズと凍結乾燥プロバイオティクス
75gの凍結乾燥L.rhamnosus(ラクトバチルス・ラムノサス)粉末を、3.6% w/w多糖および0.85% w/w NaClの250g無菌溶液中で分散させ、L.rhamnosus(ラクトバチルス・ラムノサス)懸濁液を生成した。
アルギン酸塩ビーズと凍結乾燥Bifidobacterium lactis(ビフィドバクテリウム・ラクティス)
次に示す混合物を調製した。
7.5%のB.lactis(ビフィドバクテリウム・ラクティス)(Bifido 300 B‐Bif.Lactis(ビフィドバクテリウム・ラクティス)の凍結乾燥プロバイオティクス粉末)
5% w/w濃度のアルギン酸塩を1.5%
0.85% w/w濃度のNaCl溶液を89.5%
担体として使用される次に示す添加剤のうちの1つを1.5%
・Braceミックス=プルラン
・澱粉1
・澱粉2
・デキストリン
・CMLセルロース(CMC)Na
・ヒドロキシプロピルメチルセルロース(HPMC)
・微結晶性セルロース(MC)
Claims (18)
- 固体粒子を含む乾燥粉末組成物であって、前記固体粒子は、
a)生存プロバイオティクス微生物と、
b)前記生存プロバイオティクス微生物が封入された担体相であって、前記担体相が、少なくとも栄養源と共に腸溶性組成物を更に含む、前記担体相と、を含み、
前記乾燥粉末組成物が、n〜(n+400)μmの粒度分布d 80 を示し、nが、100〜10000 μmであり、かつ、前記固体粒子が、50〜80%の前記生存プロバイオティクス微生物を含む球状粒子であることを特徴とする前記乾燥粉末組成物。 - 前記粒度分布d80が、n〜(n+200)μmであり、nが、100〜10000 μmである請求項1に記載の乾燥粉末固体粒子。
- 前記固体粒子がそれぞれ均質な組成を示す請求項1または請求項2に記載の乾燥粉末固体粒子。
- 前記担体相が、アルギン酸塩、キトサン、ペクチン、プルラン、ゼラチン、カラギーナン、および寒天からなる群より選択される少なくとも1つの物質を含む請求項1〜請求項3のいずれか1項に記載の乾燥粉末固体粒子。
- 前記少なくとも1つの物質がハイドロコロイドである請求項4に記載の乾燥粉末固体粒子。
- 前記栄養源が、単糖類、多糖類、アミノ酸、ペプチド、タンパク質、ビタミン、酵母エキス、アルカリまたはアルカリ土類金属のハロゲン塩、抗酸化剤、グリセロール、酢酸亜鉛、塩化亜鉛、乳酸亜鉛、アスコルビン酸、クエン酸または植物油、および乳脂肪からなる群より選択される化合物を少なくとも含む請求項1〜請求項5のいずれか1項に記載の乾燥粉末固体粒子。
- 前記栄養源が、乾燥粉末固体粒子の全重量に対して、0.1〜10重量%の量で含まれる請求項1〜請求項6のいずれか1項に記載の乾燥粉末固体粒子。
- アルギン酸塩、キトサン、ペクチン、プルラン、ゼラチン、カラギーナン、寒天、セルロース、ヘミセルロース、エチルセルロース、カルボキシメチルセルロース、およびこれらの混合物からなる群より選択される外部コーティングを更に含む請求項1〜請求項7のいずれか1項に記載の乾燥粉末固体粒子。
- 適切なビヒクル中に、請求項1〜請求項8のいずれか1項に記載の乾燥粉末固体粒子を含む腸溶性組成物。
- 前記適切なビヒクルが、エチルセルロース、ヒドロキシプロピルセルロース、カルボキシメチルセルロース、およびEudragit(登録商標)からなる群より選択される腸溶コーティングである請求項9に記載の腸溶性組成物。
- 軟ゲルカプセル剤、硬ゲルカプセル剤、錠剤、またはサシェ剤の形態である請求項9または請求項10に記載の腸溶性組成物。
- 球状粒子形の固体粒子を含む乾燥粉末組成物の製造方法であって、
生存プロバイオティクス微生物調製物と、少なくとも栄養源を含む担体相とを混合する工程と、
前記生存プロバイオティクス微生物調製物と前記担体相との混合物を押し出して、マイクロスフィアを製造する工程と、
凝固溶液を収容した槽で前記マイクロスフィアを回収する工程と、を含み、
押出工程を、層流ドリップキャスティングの少なくとも1つの振動ノズルを通して、0.2〜5 m/秒の所定の液体流速で行って、球状粒子形の乾燥粉末粒子を得、ここで前記振動ノズルが、1〜20000 Hzの範囲の振動数、および少なくとも0.5 μmの振幅を有することを特徴とする、前記製造方法。 - 少なくとも1つの振動ノズルからの層流ドリップキャスティングが、振動支持体によって得られることを特徴とする請求項12に記載の方法。
- 振動ノズルの振動を、液滴を発生させる流れに対して軸方向または横方向に配向させることを特徴とする請求項12または請求項13に記載の方法。
- 製造された球状粒子の径が、100〜10000 μmの範囲であることを特徴とする請求項12に記載の方法。
- 2つの液体が、内側ノズルと外側ノズルとを備えた、1つかまたは複数の二口ノズルシステムによって、層流に押し出されることを特徴とする請求項12に記載の方法。
- 押し出された混合物を封入する付加的工程を含むことを特徴とする請求項12に記載の方法。
- 外部コーティングを行う付加的工程を含むことを特徴とする請求項12に記載の方法。
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LU91782A LU91782B1 (fr) | 2011-01-21 | 2011-01-21 | Substance probiotique microencapsulee |
LU91782 | 2011-01-21 | ||
EP11151686.0 | 2011-01-21 | ||
EP11151686 | 2011-01-21 | ||
US201161503307P | 2011-06-30 | 2011-06-30 | |
US61/503,307 | 2011-06-30 | ||
PCT/EP2012/050895 WO2012098239A1 (en) | 2011-01-21 | 2012-01-20 | Microencapsulated probiotic substance and process of manufacture |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2014502989A JP2014502989A (ja) | 2014-02-06 |
JP5950938B2 true JP5950938B2 (ja) | 2016-07-13 |
Family
ID=45773666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013549833A Expired - Fee Related JP5950938B2 (ja) | 2011-01-21 | 2012-01-20 | マイクロカプセル化プロバイオティクス物質および製造方法 |
Country Status (12)
Country | Link |
---|---|
US (1) | US9554590B2 (ja) |
EP (1) | EP2665377B1 (ja) |
JP (1) | JP5950938B2 (ja) |
CN (1) | CN103458709B (ja) |
BE (1) | BE1019142A3 (ja) |
BR (1) | BR112013018344A2 (ja) |
CA (1) | CA2825011C (ja) |
DK (1) | DK2665377T3 (ja) |
ES (1) | ES2627858T3 (ja) |
MY (1) | MY161543A (ja) |
RU (1) | RU2593327C2 (ja) |
WO (1) | WO2012098239A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018230939A1 (ko) * | 2017-06-13 | 2018-12-20 | 부산대학교 산학협력단 | 산성 환경에서 프로바이오틱스를 보호하는 프로바이오틱스 전달용 하이드로겔 제제 및 이를 포함하는 프로바이오틱스 전달용 조성물 |
US11554096B2 (en) | 2017-06-13 | 2023-01-17 | Pusan National University Industry-University Cooperation Foundation | Probiotics-delivering hydrogel formulation for protecting probiotics in acidic environment and composition for delivering probiotics comprising same |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2015014915A (es) * | 2013-04-23 | 2016-03-07 | Zx Pharma Llc | Composicion multiparticulada con recubrimiento enterico que tiene un subrecubrimiento proteinico. |
CN104642539B (zh) * | 2013-11-25 | 2018-02-09 | 内蒙古蒙牛乳业(集团)股份有限公司 | 一种益生菌颗粒,其制备方法,含有其的长保质期发酵乳及制备方法 |
EP3536168A3 (en) | 2014-03-06 | 2019-10-16 | The Research Institute at Nationwide Children's Hospital | Probiotic formulations and methods for use |
US10624934B2 (en) * | 2014-03-06 | 2020-04-21 | Research Institute At Nationwide Children's Hospital | Prebiotic formulations |
KR101640744B1 (ko) * | 2014-05-07 | 2016-07-19 | 일동제약주식회사 | 고분자 다당 바인더에 컨쥬게이트된 락토바실러스 람노서스 rht-3201, 및 이의 아토피 예방 및 치료 용도 |
KR20170015315A (ko) * | 2014-06-10 | 2017-02-08 | 라이온 가부시키가이샤 | 청주 효모를 함유하는 정제 |
EP3365027B1 (en) | 2015-10-14 | 2022-03-30 | Research Institute at Nationwide Children's Hospital | Hu specific antibodies and their use in inhibiting biofilm |
CN108066314A (zh) * | 2016-11-17 | 2018-05-25 | 中国科学院大连化学物理研究所 | 一种果胶为壁材的生物微球制备方法及应用 |
SG11201906748PA (en) | 2017-01-31 | 2019-08-27 | Univ Kansas State | Microbial cells, methods of producing the same, and uses thereof |
US11191791B2 (en) | 2017-02-22 | 2021-12-07 | Praj Industries Limited | Preparation of dry formulations of dairy probiotics |
US11571387B2 (en) | 2017-03-27 | 2023-02-07 | Praj Industries Limited | Process for the preparation of powdered probiotic formulations for monogastric animals |
CN110402088A (zh) * | 2017-03-28 | 2019-11-01 | 味之素株式会社 | 用于改善肠道内环境的食品 |
FR3065162B1 (fr) * | 2017-04-13 | 2019-06-28 | Universite De Bourgogne | Microcapsules de pectine, son procede de fabrication et ses utilisations |
US10514721B2 (en) * | 2017-05-08 | 2019-12-24 | International Business Machines Corporation | Validation of clock to provide security for time locked data |
UY37944A (es) | 2017-10-20 | 2019-05-31 | Ms Biotech Inc | Métodos para producir materiales vegetales ensilados usando megasphaera elsdenii |
WO2019091970A1 (en) * | 2017-11-07 | 2019-05-16 | Purac Biochem B.V. | Acetate powder and method for the preparation thereof |
WO2019101832A1 (en) * | 2017-11-27 | 2019-05-31 | Dsm Ip Assets B.V. | Freeze-dried multiparticulate solid dosage form |
BR112020016068A2 (pt) | 2018-02-08 | 2020-12-08 | Danisco Us Inc. | Partículas cera termicamente resistente matriz para encapsulamento de enzima |
CN108576371A (zh) * | 2018-03-30 | 2018-09-28 | 大连工业大学 | 一种微胶囊包埋的双蛋白肽及其制备方法 |
GB2605271A (en) * | 2019-08-07 | 2022-09-28 | Commw Scient Ind Res Org | Compositions of probiotics and biomass and methods for promoting health in a subject |
CN110522061B (zh) * | 2019-08-28 | 2021-09-14 | 青岛职业技术学院 | 一种微胶囊及其制备方法 |
EP4034070A1 (en) * | 2019-09-24 | 2022-08-03 | GPCP IP Holdings LLC | Microencapsulated probiotic and compositions containing the same |
RU2740380C1 (ru) * | 2019-12-24 | 2021-01-13 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Биоинженерная конструкция на основе бактериального альгината и пробиотических бактерий и способ ее получения |
CN112273658A (zh) * | 2020-11-11 | 2021-01-29 | 郑州工业应用技术学院 | 一种基于内源乳化的双歧杆菌微胶囊的制备方法 |
CN112375703A (zh) * | 2020-11-12 | 2021-02-19 | 安徽燕婉健康科技有限公司 | 一种治疗型乳源性复合益生菌及其制备方法与应用 |
AU2022259587A1 (en) * | 2021-04-13 | 2023-09-07 | Illumina Cambridge Limited | Compositions, systems, and methods of making and using encapsulated lyophilised microspheres |
WO2022239810A1 (ja) * | 2021-05-11 | 2022-11-17 | 大日本印刷株式会社 | 乾燥マイクロキャリアおよびその製造方法 |
CN113730250B (zh) * | 2021-07-19 | 2023-08-25 | 珠海凤凰高科生物制药有限公司 | 一种益生菌粉末再处理方法 |
KR102464572B1 (ko) * | 2022-03-22 | 2022-11-10 | 대한켐텍 주식회사 | 프로바이오틱스 캡슐제 |
WO2023209224A1 (en) | 2022-04-29 | 2023-11-02 | Université Libre de Bruxelles | Probiotics for the prevention or treatment of viral respiratory infections |
CN115777937B (zh) * | 2023-01-30 | 2023-05-16 | 山东瑞安泰医疗技术有限公司 | 一种内嵌多元营养微球的减节食胶囊及其制备方法 |
CN117586930B (zh) * | 2024-01-19 | 2024-04-16 | 北京市农林科学院 | 一种用于降解展青霉素的微囊材料及其制备方法和应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60221078A (ja) | 1984-04-18 | 1985-11-05 | Morinaga Milk Ind Co Ltd | 有用微生物粉末の粒状製品およびその製造法 |
KR100387245B1 (ko) * | 1997-10-17 | 2003-08-19 | 일양약품주식회사 | 유산균의안정화를위한미세장용성코팅과립 |
EP1065936B1 (en) | 1998-03-23 | 2009-08-05 | General Mills, Inc. | Encapsulation of components into edible products |
EP1344458A1 (en) * | 2002-03-12 | 2003-09-17 | Société des Produits Nestlé S.A. | Probiotic delivery system |
US20050266069A1 (en) | 2002-09-06 | 2005-12-01 | Simmons Donald L | Stable probiotic microsphere compositions and their methods of preparation |
US20040247580A1 (en) | 2003-06-06 | 2004-12-09 | Myung-Jun Chung | Process for preparing double-coated lactic acid bacteria powder using protein and polysaccharide and product by the same |
CN1613455A (zh) * | 2003-11-04 | 2005-05-11 | 北京东方百信生物技术有限公司 | 靶向益生菌微胶囊及其制备方法 |
US20060099247A1 (en) * | 2004-11-10 | 2006-05-11 | Byrd-Walsh, Llc. | Liquid, gas and/or vapor phase delivery systems |
ES2368344T3 (es) * | 2005-05-18 | 2011-11-16 | Dsm Ip Assets B.V. | Composiciones para aplicación parenteral de microorganismos. |
EP1981338A2 (en) * | 2006-01-13 | 2008-10-22 | Advanced Bionutrition Corporation | Continuous spray-capture production system |
CN100469869C (zh) * | 2006-09-08 | 2009-03-18 | 哈尔滨美华生物技术股份有限公司 | 一种肠道益生菌包埋保护方法 |
US20100189767A1 (en) * | 2006-09-19 | 2010-07-29 | Eyal Shimoni | Probiotic compositions and methods of making same |
CN100537759C (zh) * | 2006-12-04 | 2009-09-09 | 济南赛拜斯生物工程有限公司 | 肠溶性多层包被益生菌微胶囊及其制备方法 |
CN101323850B (zh) * | 2008-07-28 | 2011-05-04 | 天津科技大学 | 瑞士乳杆菌微胶囊及其制备与应用 |
-
2011
- 2011-11-02 BE BE2011/0633A patent/BE1019142A3/fr active
-
2012
- 2012-01-20 EP EP12700703.7A patent/EP2665377B1/en active Active
- 2012-01-20 MY MYPI2013002688A patent/MY161543A/en unknown
- 2012-01-20 BR BR112013018344A patent/BR112013018344A2/pt not_active Application Discontinuation
- 2012-01-20 CN CN201280005852.9A patent/CN103458709B/zh not_active Expired - Fee Related
- 2012-01-20 CA CA2825011A patent/CA2825011C/en not_active Expired - Fee Related
- 2012-01-20 ES ES12700703.7T patent/ES2627858T3/es active Active
- 2012-01-20 RU RU2013138291/13A patent/RU2593327C2/ru not_active IP Right Cessation
- 2012-01-20 JP JP2013549833A patent/JP5950938B2/ja not_active Expired - Fee Related
- 2012-01-20 US US13/980,526 patent/US9554590B2/en active Active
- 2012-01-20 DK DK12700703.7T patent/DK2665377T3/en active
- 2012-01-20 WO PCT/EP2012/050895 patent/WO2012098239A1/en active Application Filing
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018230939A1 (ko) * | 2017-06-13 | 2018-12-20 | 부산대학교 산학협력단 | 산성 환경에서 프로바이오틱스를 보호하는 프로바이오틱스 전달용 하이드로겔 제제 및 이를 포함하는 프로바이오틱스 전달용 조성물 |
US11554096B2 (en) | 2017-06-13 | 2023-01-17 | Pusan National University Industry-University Cooperation Foundation | Probiotics-delivering hydrogel formulation for protecting probiotics in acidic environment and composition for delivering probiotics comprising same |
Also Published As
Publication number | Publication date |
---|---|
JP2014502989A (ja) | 2014-02-06 |
CN103458709A (zh) | 2013-12-18 |
CA2825011C (en) | 2019-09-03 |
CA2825011A1 (en) | 2012-07-26 |
BE1019142A3 (fr) | 2012-03-06 |
ES2627858T3 (es) | 2017-07-31 |
RU2593327C2 (ru) | 2016-08-10 |
CN103458709B (zh) | 2017-10-03 |
RU2013138291A (ru) | 2015-02-27 |
US9554590B2 (en) | 2017-01-31 |
BR112013018344A2 (pt) | 2017-06-13 |
US20140010918A1 (en) | 2014-01-09 |
EP2665377B1 (en) | 2017-03-08 |
WO2012098239A1 (en) | 2012-07-26 |
MY161543A (en) | 2017-04-28 |
DK2665377T3 (en) | 2017-06-19 |
EP2665377A1 (en) | 2013-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5950938B2 (ja) | マイクロカプセル化プロバイオティクス物質および製造方法 | |
Kavitake et al. | Recent developments on encapsulation of lactic acid bacteria as potential starter culture in fermented foods–A review | |
Razavi et al. | Microencapsulating polymers for probiotics delivery systems: Preparation, characterization, and applications | |
US11911516B2 (en) | Protection of microbial cells from acidic degradation | |
Martín et al. | Microencapsulation of bacteria: A review of different technologies and their impact on the probiotic effects | |
Anal et al. | Recent advances in microencapsulation of probiotics for industrial applications and targeted delivery | |
US6841181B2 (en) | Encapsulated multifunctional biologically active food component, process for its production and its use | |
CA2538676C (en) | Probiotic storage and delivery | |
JP2012527898A5 (ja) | ||
AU2012210575A1 (en) | Protection of microbial cells from acidic degradation | |
Xing et al. | Effect of porous starch concentrations on the microbiological characteristics of microencapsulated Lactobacillus acidophilus | |
JP2019503707A (ja) | 糖類を全くまたはほとんど含有しない安定した乾燥組成物 | |
EP2608679A2 (en) | Method for enhancing the shelf stability of probiotics | |
JP2006280263A (ja) | ビフィズス菌菌体粉末 | |
Vandamme et al. | Microencapsulation of probiotics | |
Zhou et al. | Evaluation of Streptococcus thermophilus IFFI 6038 microcapsules prepared using an ultra-fine particle processing system | |
Petreska Ivanovska et al. | Comparative evaluation of viability of encapsulated Lactobacillus casei using two different methods of microencapsulation | |
US11426353B2 (en) | Composite coating for an active agent | |
AU2004275438B2 (en) | Probiotic storage and delivery | |
Martın et al. | ÔØ Å ÒÙ× Ö ÔØ | |
Kavitake et al. | Food Bioscience |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140903 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150811 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151106 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160510 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160607 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5950938 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |